Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 10.0B | 9.4B | 9.3B | 9.1B |
Cost of revenue | 2.2B | 2.1B | 2.2B | 2.2B |
Gross profit | 7.8B | 7.3B | 7.2B | 7.0B |
Operating expense | ||||
Research & development | 1.4B | 1.4B | 1.3B | 1.4B |
Selling general and admin | 4.2B | 4.0B | 3.9B | 3.9B |
Other operating expenses | — | — | — | — |
Operating income | 2.1B | 1.9B | 1.9B | 1.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | -130M | -203M | -45M | 150M |
Pretax income | 2.0B | 1.7B | 1.8B | 1.9B |
Tax provision | 280M | 219M | 408M | 334M |
Net income | 1.7B | 1.5B | 1.4B | 1.5B |
Basic EPS | — | 1.6 | 1.5 | 1.6 |
Diluted EPS | — | 1.6 | 1.5 | 1.6 |
Basic average shares | — | 956M | 964M | 970M |
Diluted average shares | — | 965M | 973M | 985M |
EBITDA | 3.2B | 3.0B | 2.9B | 2.6B |
Net income from continuing op. | 1.7B | 1.5B | 1.4B | 1.5B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |